Zehra S. Isleyen

Prof. Dr. Cemil Tascıoglu City Hospital
Istanbul, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma.

Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma.

Journal: Immunotherapy

Published: September 02, 2026

Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy.

Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy.

Journal: Cancers

Published: June 09, 2026

Maintenance pemetrexed after platinum pemetrexed chemotherapy and survival outcomes in malignant pleural mesothelioma in a multicenter real world study.

Maintenance pemetrexed after platinum pemetrexed chemotherapy and survival outcomes in malignant pleural mesothelioma in a multicenter real world study.

Journal: Scientific reports

Published: March 19, 2026

Clinical Significance of Achieving No Evidence of Disease in HER2-Positive Metastatic Breast Cancer: A Multicenter Study by Turkish Oncology Group (TOG).

Clinical Significance of Achieving No Evidence of Disease in HER2-Positive Metastatic Breast Cancer: A Multicenter Study by Turkish Oncology Group (TOG).

Journal: Cancers

Published: February 12, 2026

Neoadjuvant anthracycline-free versus anthracycline-containing chemotherapy combined with dual HER2 blockade in HER2-positive breast cancer: a real-world comparative study.

Neoadjuvant anthracycline-free versus anthracycline-containing chemotherapy combined with dual HER2 blockade in HER2-positive breast cancer: a real-world comparative study.

Journal: Breast cancer research : BCR

Published: January 17, 2026

The Effect of Total Neoadjuvant Treatment on Pathological Response and Survival in Locally Advanced Rectal Cancer: A Single Center Experience.

The Effect of Total Neoadjuvant Treatment on Pathological Response and Survival in Locally Advanced Rectal Cancer: A Single Center Experience.

Journal: Clinical colorectal cancer

Published: April 17, 2025

Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study.

Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study.

Journal: Scientific reports

Published: March 19, 2025

The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study.

The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study.

Journal: Scientific reports

Published: May 18, 2024

Cardiac safety of ribociclib evaluated with 24-hour rhythm Holter electrocardiogram.

Cardiac safety of ribociclib evaluated with 24-hour rhythm Holter electrocardiogram.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: January 30, 2024

Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases.

Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases.

Journal: Scientific reports

Published: November 23, 2023

The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey.

The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey.

Journal: Medicine

Published: November 14, 2023

The correlation between skeletal muscle index and anxiety in patients with lung cancer on the first day of chemotherapy.

The correlation between skeletal muscle index and anxiety in patients with lung cancer on the first day of chemotherapy.

Journal: Future oncology (London, England)

Published: June 27, 2023

Showing 1-12 of 14

Last Updated: 09/26/2026